|
|
|
|
|
|
by milesskorpen
3886 days ago
|
|
|
Accounting rules changed after Enron; it's a lot harder to do what they did. The biggest recent drop was after a very negative piece from someone who publishes negative pieces while short-selling. I don't have much information, but I'm not all that convinced Valeant has real fraud issues. Also, Theranos and Valeant seem like entirely different businesses. |
|
|
I think you're missing the point I was making: Valeant is a timely and interesting example of what can happen to the valuation of a company under fire.
> I don't have much information, but I'm not all that convinced Valeant has real fraud issues.
If you don't have much information, how can you be convinced of anything one way or the other?